Moomoo AIのまとめ
On December 31, 2023, a Schedule 13G amendment was filed with the SEC by Intelligent Bio Solutions Inc., indicating a significant ownership stake by Lind Global Fund II LP, Lind Global Partners II LLC, and Jeff Easton. The filing, which is a regulatory requirement for parties owning more than five percent of a company's stock, shows that these entities and individual collectively hold 960,000 shares of Intelligent Bio Solutions' common stock, representing 9.9% of the company. The ownership consists of warrants to purchase common stock, but due to exercise limitations, the beneficial ownership is capped at 960,000 shares. Jeff Easton, as the managing member of Lind Global Partners II LLC and the general partner of Lind Global Fund II LP, is deemed to have sole voting and dispositive power over the shares held by Lind Global Fund II LP. The principal business office for all reporting persons is located at 444 Madison Ave, Floor 41, New York, NY 10022. The filing, dated February 13, 2024, includes a joint filing agreement among the reporting persons.
On December 31, 2023, a Schedule 13G amendment was filed with the SEC by Intelligent Bio Solutions Inc., indicating a significant ownership stake by Lind Global Fund II LP, Lind Global Partners II LLC, and Jeff Easton. The filing, which is a regulatory requirement for parties owning more than five percent of a company's stock, shows that these entities and individual collectively hold 960,000 shares of Intelligent Bio Solutions' common stock, representing 9.9% of the company. The ownership consists of warrants to purchase common stock, but due to exercise limitations, the beneficial ownership is capped at 960,000 shares. Jeff Easton, as the managing member of Lind Global Partners II LLC and the general partner of Lind Global Fund II LP, is deemed to have sole voting and dispositive power over the shares held by Lind Global Fund II LP. The principal business office for all reporting persons is located at 444 Madison Ave, Floor 41, New York, NY 10022. The filing, dated February 13, 2024, includes a joint filing agreement among the reporting persons.
2023年12月31日、Intelligent Bio Solutions Inc.がSECに提出したスケジュール13G修正案によると、Lind Global Fund II LP、Lind Global Partners II LLC、およびJeff Eastonによる重要な所有権が示された。規制要件である会社の株式の5％以上の持ち主のためのこの申告により、これらの団体と個人がIntelligent Bio Solutionsの普通株式の960,000株、つまり同社の9.9％を保有していることが示されています。この所有権には普通株式を購入するためのワラントが含まれますが、行使制限により、有利...すべて展開
2023年12月31日、Intelligent Bio Solutions Inc.がSECに提出したスケジュール13G修正案によると、Lind Global Fund II LP、Lind Global Partners II LLC、およびJeff Eastonによる重要な所有権が示された。規制要件である会社の株式の5％以上の持ち主のためのこの申告により、これらの団体と個人がIntelligent Bio Solutionsの普通株式の960,000株、つまり同社の9.9％を保有していることが示されています。この所有権には普通株式を購入するためのワラントが含まれますが、行使制限により、有利な所有権は960,000株に制限されています。Lind Global Fund II LPが保有する株式に関しては、Lind Global Partners II LLCの経営メンバーであるJeff Eastonが単独で投票権および処分権を有するものとみなされています。すべての報告者の主な事務所は、ニューヨーク、マディソンアベニュー444号41階にあります。2024年2月13日付のこの申告には報告者間の共同申告契約が含まれています。
役に立った
役に立たない